Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 6:50 PM
Ignite Modification Date: 2025-12-25 @ 4:22 PM
NCT ID: NCT00525057
Description: None
Frequency Threshold: 5
Time Frame: 4 weeks after surgery
Study: NCT00525057
Study Brief: Dalteparin in Preventing DVT in Participants With Cancer
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Interventional (Dalteparin, Sarcoma) Received dalteparin 5000 units daily postop, patients with primary sarcomas. 0 None 0 25 4 25 View
Interventional (Dalteparin, Metastatic) Received dalteparin 5000 units daily postop, patients with metastatic disease. 0 None 1 25 1 25 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Thromboembolic event SYSTEMATIC_ASSESSMENT Vascular disorders CTCAE (4.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Seroma SYSTEMATIC_ASSESSMENT Surgical and medical procedures CTCAE (4.0) View
Wound infection SYSTEMATIC_ASSESSMENT Surgical and medical procedures CTCAE (4.0) View